标题
MiRNA-21
作者
关键词
-
出版物
CANCER BIOLOGY & THERAPY
Volume 13, Issue 5, Pages 330-340
出版商
Informa UK Limited
发表日期
2012-03-28
DOI
10.4161/cbt.19073
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Predictive markers in the adjuvant therapy of non-small cell lung cancer
- (2011) Martin Filipits et al. LUNG CANCER
- Clinicopathological and Prognostic Value of MicroRNA-21 and MicroRNA-155 in Colorectal Cancer
- (2011) Hajime Shibuya et al. ONCOLOGY
- Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
- (2011) Bin Bao et al. PLoS One
- Integration of Transcriptomics, Proteomics, and MicroRNA Analyses Reveals Novel MicroRNA Regulation of Targets in the Mammalian Inner Ear
- (2011) Tal Elkan-Miller et al. PLoS One
- Identification of plasma microRNA-21 as a biomarker for early detection and chemosensitivity of non-small cell lung cancer
- (2011) Juan Wei et al. Chinese Journal of Cancer
- MiRNAs and Their Association with Locoregional Staging and Survival Following Surgery for Esophageal Carcinoma
- (2010) Richard Hummel et al. ANNALS OF SURGICAL ONCOLOGY
- Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis
- (2010) Wen Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- The overexpression of ERCC-1 is involved in the resistance of lung cancer cells to cetuximab combined with DDP
- (2010) Jing-Jing Li et al. CANCER BIOLOGY & THERAPY
- Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells
- (2010) Yukihiro Akao et al. CANCER LETTERS
- Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer
- (2010) Zhibin Hu et al. JOURNAL OF CLINICAL ONCOLOGY
- AP-1-Dependent miR-21 Expression Contributes to Chemoresistance in Cancer Stem Cell-Like SP Cells
- (2010) Aya Misawa et al. ONCOLOGY RESEARCH
- Increase of microRNAmiR-31level in plasma could be a potential marker of oral cancer
- (2010) C-J Liu et al. ORAL DISEASES
- MicroRNAs: Novel regulators in the hallmarks of human cancer
- (2009) Kai Ruan et al. CANCER LETTERS
- Chemoresistant Colorectal Cancer Cells, the Cancer Stem Cell Phenotype, and Increased Sensitivity to Insulin-like Growth Factor-I Receptor Inhibition
- (2009) N. A. Dallas et al. CANCER RESEARCH
- Emerging Data with Antiangiogenic Therapies in Early and Advanced Non–Small-Cell Lung Cancer
- (2009) Leora Horn et al. Clinical Lung Cancer
- Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
- (2009) Guilherme Rabinowits et al. Clinical Lung Cancer
- Chemotherapy for lung cancer: the state of the art in 2009
- (2009) Michaela J Higgins et al. Expert Review of Anticancer Therapy
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
- (2009) Ram Eitan et al. GYNECOLOGIC ONCOLOGY
- Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
- (2009) Zhaohui Huang et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non–Small-Cell Lung Cancer
- (2009) Hua Bai et al. JOURNAL OF CLINICAL ONCOLOGY
- MicroRNAs in colorectal cancer: translation of molecular biology into clinical application
- (2009) Ondrej Slaby et al. Molecular Cancer
- Comparison of SYBR Green I and TaqMan real-time PCR formats for the analysis of her2 gene dose in human breast tumors
- (2008) N. U. Matsenko et al. BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
- MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN
- (2008) H. Yang et al. CANCER RESEARCH
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue
- (2008) T.-S. Wong et al. CLINICAL CANCER RESEARCH
- Prognostic Value of Mature MicroRNA-21 and MicroRNA-205 Overexpression in Non-Small Cell Lung Cancer by Quantitative Real-Time RT-PCR
- (2008) A. Markou et al. CLINICAL CHEMISTRY
- The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform
- (2008) Kimberly E. Resnick et al. GYNECOLOGIC ONCOLOGY
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
- (2008) Mary Dillhoff et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNAs modulate the chemosensitivity of tumor cells
- (2008) P. E. Blower et al. MOLECULAR CANCER THERAPEUTICS
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
- (2008) L.-X. Yan et al. RNA
- Real-time RT-PCR assay for rapid and specific detection of classical swine fever virus: Comparison of SYBR Green and TaqMan MGB detection methods using novel MGB probes
- (2007) Urška Jamnikar Ciglenečki et al. JOURNAL OF VIROLOGICAL METHODS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started